81
Views
38
CrossRef citations to date
0
Altmetric
Original Articles

Multidisciplinary Approach to the Treatment of Metabolic and Morphologic Alterations of HIV-Related Lipodystrophy

, , , , , , , , , , , , , , , , , & show all
Pages 97-106 | Published online: 02 Feb 2015

REFERENCES

  • Miller J, Carr A, Emery S, et al. HIV lipodystrophy: preva-lence, severity and correlates of risk in Australia. HIV Med. 2003;4:293–301.
  • Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ, Cooper DA. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet. 1999;353:2093–2099.
  • Gervasoni C, Ridolfo AL, Trifiro G, et al. Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy. AIDS. 1999;13:465–471.
  • Lichtenstein KA, Ward DJ, Moorman AC, et al. Clinical assessment of HIV-associated lipodystrophy in an ambula-tory population. AIDS. 2001;15:1389–1398.
  • Bernasconi E, Boubaker K, Junghans C, et al. Abnormali-ties of body fat distribution in HIV-infected persons treated with antiretroviral drugs: the Swiss HIV Cohort Study. J Acquir Immune Defic Syndr. 2002;31:50–55.
  • Currier JS, Taylor A, Boyd F, et al. Coronary heart disease in HIV-infected individuals. J Acquir Immune Defic Syndr. 2003;33:506–512.
  • The Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med. 2003;349:1993-2003. [ Erratum, N Engl J Med. 2004; 350: 955]
  • D'Arminio A, Sabin CA, Phillips AN, et al. Cardio- and cerebrovascular events in HIV-infected persons. AIDS. 2004;18:1811–1817.
  • Colins E, Wagner C, Walmsley S. Psychological impact of lipodystrophy syndrome in HIV infection. AIDS Reader. 2000;10:546–551.
  • Martinez E, Garcia-Viejo MA, Blanch J, Gate!! JM. Lipodys-trophy syndrome in patients with HIV infection: quality of life issue [review]. Drug Sal. 2001;24:157–166.
  • Dukers N, Stolte IG, Albrecht N, Coutinho RA, de Wit JBF. The impact of experiencing lipodystrophy on the sexual behaviour and well-being among HIV-infected homosexual men. AIDS. 2001;15:812–813.
  • Blanch J, Rousaud A, Martynez E, et al. Impact of lipodys-trophy on the quality of life of HIV-1-infected patients. J Acquir Immune Defic Syndr. 2002;31:404–407.
  • Schambelan M, Benson CA, Carr A, et al., International AIDS Society-USA. Management of metabolic complica-tions associated with antiretroviral therapy for HIV-1 infec-tion: recommendations of an International AIDS Society-USA panel. J Acquir Immune Defic Syndr. 2002; 31(3):257–275.
  • Dube MP, Stein JH, Aberg JA, et al., Adult AIDS Clinical Trials Group Cardiovascular Subcommittee, HIV Medical Association of the Infectious Disease Society of America. Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-in-fected adults receiving antiretroviral therapy: recommen-dations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group. Clin Infect Dis. 2003;37(5):613–627.
  • Grinspoon S, Carr A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med. 2005;352(1):48–62.
  • Panel on Clinical Practices for Treatment of HIV Infection convened by the Department of Health and Human Ser-vices (DH HS). Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents - October 29, 2004. Available at: http://aidsinfo.nih.gov/guidelines/default_db2.asp?id=50. Accessed January 9, 2005.
  • Kingsley L, Smit E, Riddler S, et al. Prevalence of lipodys-trophy and metabolic abnormalities in the Multicenter AIDS Cohort Study (MACS). In: Program and abstracts of the 8th Conference on Retroviruses and Opportunistic Infections; February 4–8, 2001; Chicago. Abstract 538.
  • Guaraldi G, Orlando G, Murri R, et al. Validation of an Italian version of the ACTG assessment of body change and distress (ABCD) questionnaire. In: Program and abstracts of the AIDS Impact - 6th International Conference; July 7–10, 2003; Milan. Abstract book, p. 8.2.
  • Beck AT, Steer RA, Garbin MG, Psychometric properties of the Beck Depression Inventory: Twenty-five years of evalu-ation. Clin Psycho! Rev. 1988:8(1):77–100.
  • Brown C, Schulberg HC, Madonia MJ. Assessing depres-sion in primary care practice with the Beck Depression Inventory and the Hamilton Rating Scale for Depression. Psycho! Assess. 1995 ;7(1):59–65.
  • Wu AW, Rubin HR, Mathews WC, et al. A health status questionnaire using 30 items from the Medical Outcomes Study. Preliminary validation in persons with early HIV infection. Med Care. 1991;29(8):786–798.
  • Revicki DA, Sorenses S, Wu AW. Reliability and validity of physical and mental health summary scores from the Medical Outcome Study HIV Health Survey. Med Care. 1998;36(2):126–137.
  • Murri R, Ammassari A, Fantoni M, Wu AW, et al. Disease-related factors associated with health-related quality of life in people with nonadvanced HIV disease assessed using an Italian version of the MOS-HIV Health Survey. J Acquir Immune Defic Syndr Hum RetroviroL 1997;16(5):350–356.
  • Mussini C, Bugarini R, Perno CF, et al. Kinetics of CD4 cells after discontinuation of antiretroviral therapy in patients with virological failure and a CD4 cell count greater than 500 cells/microl. AIDS. 2002;16(11):1551–1554.
  • Keeton WP, Cash TF, Brown TA. Body image or body images? A comparative, multidimensional assessment among college students. J Pers Assess. 1990;54(1 & 2):213–230.
  • Cash TF. Physical appearance and mental health. In: Gra-ham JA, Kligman A, eds. The Psychology of Cosmetic Treatments. New York: Praeger, 1985:196–216.
  • Hatfield E, Sprecher S. Mirror, Mirror...: The Importance of Looks in Everyday Life. Albany: State University of New York Press; 1986.
  • Cash IF. Body-image attitudes: evaluation, investment and affect. Percept Motor Skills. 1994;78:1168–1170.
  • Cash TF, Green GK. Body weight and body image among college women: perception, cognition and affect. J Pers Assess. 1986;50:290–301
  • Martin A, Smith DE, Carr A, et al., Mitochondria! Toxicity Study Group. Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study. AIDS. 2004;18(7):1029–1036.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.